Boost to Melanoma Services in the Riverina
12 December 2019
Melanoma patients and their families throughout the Riverina region will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia..
The merger was announced at the 10th Anniversary Celebrations for the Amie St Clair Melanoma Trust, which was formed by Annette and Peter St Clair in memory of their daughter Amie who passed away from melanoma when she was just 23 years old.
It will provide immediate benefits by doubling the level of services provided to melanoma patients in the Riverina, including:
- Increased capacity of the free melanoma nursing services;
- The establishment of clinical trials in Wagga Wagga;
- Opportunities for melanoma patients within the region to contribute to MIA research;
- Melanoma Education opportunities – both professional (GPs/Clinics) and community-based through the SunSafe Student Ambassador program.
The merged entity will retain its local office presence in Wagga Wagga, as well as the dedicated service of both Annette and Peter St Clair. Importantly, the legacy of Amie St Clair will be maintained.
Annette St Clair said she is excited by the opportunities created through MIA. ‘Pete and I just can’t believe we will have clinical trials established here and we are really excited that MIA is using the Amie St Clair Trust model as the framework to increase services in other parts of regional Australia,'
‘Our wonderful volunteers have worked so hard to build the Amie St Clair Melanoma Trust over the last 10 years, and this partnership with MIA will significantly increase melanoma services for the next 10 years.’
Melanoma Institute Australia CEO Matthew Browne attended the 10th Anniversary Celebrations and paid tribute to the tireless work of Annette and Peter St Clair, plus the all the volunteers, in raising awareness of melanoma and supporting local patients and their families.
‘We love what the Amie St Clair Melanoma Trust has been doing and together we have built a strong relationship over the past few years,’ Mr Browne said. ‘Our shared vision is zero deaths from melanoma, no matter where you live, and this is a fantastic opportunity to enhance the effective delivery of treatment and support services to melanoma patients in this region.
‘We can then go to Government with a proven collaborative model and hopefully extend melanoma support services to other regional centres as well.’
The newly merged entity will be officially launched at an event in Wagga on 27 February 2020 and its first major fundraising event will be Melanoma March Wagga on 15 March at Apex Park.
Pictured in photo: Annette St Clair and Moo, from Amie St Clair Melanoma Trust
Australasian Melanoma Conference AMC2021
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Community Fundraising Wrap Up Apr-June 2021
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Patients paying it forward
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
Research boost to improve outcomes for melanoma patients
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Riverina Melanoma Ride
Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina this October, to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Amie St Clair 10th Annual Ball
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Melanoma Clinical Trial to open in Wagga
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
Queen's Birthday Honour for Professor Richard Scolyer
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
Sharing our research on the global stage at 2021 ASCO Annual Meeting
Research from MIA was once again in the spotlight as findings were shared at the virtual ASCO21.
Australian researchers lead world in successful trial of new cancer treatment.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Thank you doesn't seem enough for our melanoma nurses.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
Sharing our knowledge of melanoma on the global stage
As leaders in the field of melanoma, clinicians and researchers from MIA shared their knowledge at the virtual 10th World Congress of Melanoma.
Community Fundraising Wrap Up Jan-Mar 2021
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their families urged to speak up and put national spotlight on melanoma.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
Support for Melanoma March has come from everywhere
We have been buoyed by the wonderful support for our Melanoma March campaign, and our mission to cover Australia in footprints continues into April!
An inspiring WA Melanoma Community Forum
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
Family of 8-year-old with melanoma calls on all Australians to step up to help save lives
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
Rethinking skin surveillance for high-risk melanoma patients
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Australia's oldest melanoma survivor steps up to save lives on his 105th birthday
Melanoma research saved Bert's life at 101 and now he wants to give back.
Predicting disease spread in thin melanoma
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.